Bionomics Limited (BNOX)
USD 0.25
(4.59%)
USD 0.25
(4.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -17.89 Billion USD | -55866.14% |
| 2023 | -31.97 Million USD | -49.81% |
| 2022 | -21.34 Million USD | -79.03% |
| 2021 | -11.92 Million USD | -32.3% |
| 2020 | -9.01 Million USD | 41.34% |
| 2019 | -15.36 Million USD | 13.71% |
| 2018 | -17.8 Million USD | -321.43% |
| 2017 | -4.22 Million USD | 64.78% |
| 2016 | -11.99 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.41 Million USD | 74.26% |
| 2024 Q4 | -1.67 Million USD | 0.0% |
| 2024 Q2 | -13.74 Million USD | -211.09% |
| 2023 Q3 | -4.34 Million USD | 70.68% |
| 2023 Q1 | -4.73 Million USD | -14.12% |
| 2023 Q2 | -14.82 Million USD | -212.71% |
| 2023 FY | -18.52 Million USD | -52.51% |
| 2023 Q4 | -17.16 Million USD | -294.87% |
| 2022 Q4 | -4.15 Million USD | 0.0% |
| 2022 FY | -12.14 Million USD | -57.67% |
| 2022 Q2 | -8.41 Million USD | 0.0% |
| 2021 Q2 | -3.17 Million USD | 0.0% |
| 2021 Q4 | -7.14 Million USD | 0.0% |
| 2021 FY | -7.7 Million USD | -49.15% |
| 2020 FY | -5.16 Million USD | 41.81% |
| 2020 Q2 | -3.29 Million USD | 0.0% |
| 2020 Q4 | -3.47 Million USD | 0.0% |
| 2019 Q4 | -1.86 Million USD | 0.0% |
| 2019 FY | -8.87 Million USD | 50.12% |
| 2018 FY | -17.8 Million USD | -321.43% |
| 2017 FY | -4.22 Million USD | 64.78% |
| 2016 FY | -11.99 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -7442.938% |
| Alkermes plc | 414.12 Million USD | 4420.557% |
| Agenus Inc. | -159.54 Million USD | -11114.345% |
| Aptorum Group Limited | -10.52 Million USD | -169925.8% |
| Ardelyx, Inc. | -63.27 Million USD | -28176.718% |
| Dyadic International, Inc. | -8.22 Million USD | -217311.22% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -1500938.255% |
| Lantern Pharma Inc. | -17.87 Million USD | -99982.819% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -88962.027% |
| Novavax, Inc. | -566.51 Million USD | -3058.346% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -24417.157% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -21667.94% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -92040.8% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -169287.257% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -33578.89% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -4602.382% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -73511.16% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -47148.082% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -13771.349% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -21222.278% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -101914.801% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -40555.251% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -71918.902% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -12769.343% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -6240.879% |
| AlloVir, Inc. | -181.33 Million USD | -9767.246% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -8627.903% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -61053.79% |
| Bicycle Therapeutics plc | -189.94 Million USD | -9319.717% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -10315.746% |
| ChromaDex Corporation | -5.59 Million USD | -319463.779% |
| Chimerix, Inc. | -93.06 Million USD | -19125.677% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -39592.652% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -15316.621% |
| CRISPR Therapeutics AG | -222.53 Million USD | -7940.144% |
| Precision BioSciences, Inc. | -43.73 Million USD | -40809.951% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -9291.781% |
| Fortress Biotech, Inc. | -142.34 Million USD | -12469.991% |
| Fortress Biotech, Inc. | -142.34 Million USD | -12469.991% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -18214.713% |
| ImmuCell Corporation | -5.74 Million USD | -311175.804% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -13209.908% |
| Immix Biopharma, Inc. | -16.14 Million USD | -110749.704% |
| Incyte Corporation | 620.52 Million USD | 2983.425% |
| Innoviva, Inc. | 176.7 Million USD | 10225.334% |
| IO Biotech, Inc. | -91.44 Million USD | -19466.698% |
| Jaguar Health, Inc. | -34.29 Million USD | -52078.053% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -10428.581% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 149927.299% |
| ContextLogic Inc. | -328 Million USD | -5354.993% |
| MiMedx Group, Inc. | 37.11 Million USD | 48306.639% |
| MEI Pharma, Inc. | 14.54 Million USD | 123139.307% |
| NextCure, Inc. | -67.63 Million USD | -26353.533% |
| Onconetix, Inc. | -36.03 Million USD | -49553.329% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -42792.976% |
| Opthea Limited | -191.84 Million USD | -9226.585% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -650100.358% |
| Vaxcyte, Inc. | -468.04 Million USD | -3722.822% |
| PDS Biotechnology Corporation | -43.04 Million USD | -41466.451% |
| Precigen, Inc. | -88.92 Million USD | -20021.201% |
| Pharming Group N.V. | -4.87 Million USD | -366581.313% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -10594.018% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -60030.313% |
| PureTech Health plc | -146.19 Million USD | -12138.371% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -87218.218% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -7494.452% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -73511.16% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -6429.945% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -60955.711% |
| Acelyrin, Inc. | -422.06 Million USD | -4139.257% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -138754915.533% |
| Summit Therapeutics Inc. | -89.73 Million USD | -19838.905% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -48174.272% |
| Senti Biosciences, Inc. | -92.72 Million USD | -19195.756% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -15489.36% |
| Elevation Oncology, Inc. | -45.44 Million USD | -39271.495% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -52114.597% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -453785.29% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -565756.293% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -54084.84% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -210373.78% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -26213.866% |
| Seer, Inc. | -103.46 Million USD | -17193.502% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -27109.015% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -24773.669% |
| ESSA Pharma Inc. | -32.13 Million USD | -55580.333% |
| GlycoMimetics, Inc. | -39.27 Million USD | -45456.315% |
| GT Biopharma, Inc. | -13.57 Million USD | -131694.166% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -8061.798% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -38581.2% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 20710.487% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -31423.417% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -34638.43% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -179946.44% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -3447.857% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -259284.981% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -35195.556% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -6790.721% |
| Aptose Biosciences Inc. | -52.35 Million USD | -34074.452% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -123973.618% |
| Soligenix, Inc. | -7.69 Million USD | -232330.702% |
| Century Therapeutics, Inc. | -146.54 Million USD | -12109.392% |
| Kura Oncology, Inc. | -165.8 Million USD | -10691.281% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -19044.831% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -214978.447% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -720890.281% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -275846.576% |
| Autolus Therapeutics plc | -195.02 Million USD | -9074.26% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -21035.141% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -24189.832% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -84557.563% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -7780.889% |
| GRI Bio, Inc. | -11.38 Million USD | -157029.85% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -396124.651% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -13538.209% |
| IGM Biosciences, Inc. | -263.46 Million USD | -6691.281% |
| INmune Bio, Inc. | -29.74 Million USD | -60060.64% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -16075.361% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -46892.057% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -111871.787% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -113352.364% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -29184.716% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -16540.665% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -6382.604% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -8705.346% |
| Verastem, Inc. | -92.08 Million USD | -19330.494% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -37859.851% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -9616.46% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -15014.357% |
| Histogen Inc. | -10.64 Million USD | -168014.028% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -115543.887% |
| Surrozen, Inc. | -45.78 Million USD | -38983.39% |
| Organovo Holdings, Inc. | -15.08 Million USD | -118502.519% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -351403.86% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -30082.075% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -34782.006% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -70676.804% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -234312.997% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -10346.09% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -36831.128% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -22778.813% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -117452.34% |
| Apollomics, Inc. | -54.83 Million USD | -32530.076% |
| Amarin Corporation plc | -67.58 Million USD | -26372.711% |
| Mesoblast Limited | -58.79 Million USD | -30332.316% |
| Turnstone Biologics Corp. | -59.03 Million USD | -30209.622% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -10709.144% |
| Synaptogenix, Inc. | -8.31 Million USD | -215111.573% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -122568.148% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -19413.776% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -373321.746% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -202503.328% |
| Exelixis, Inc. | 170.88 Million USD | 10570.419% |
| Better Therapeutics, Inc. | -38.26 Million USD | -46662.783% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -11438.778% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -3359.998% |
| NLS Pharmaceutics AG | -11.8 Million USD | -151439.6% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -222389.246% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -59555.173% |
| Gritstone bio, Inc. | -154.63 Million USD | -11470.79% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -25883.323% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -104392.914% |
| Avid Bioservices, Inc. | -18.67 Million USD | -95693.854% |
| Insmed Incorporated | -709.62 Million USD | -2421.381% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -113938.354% |
| MediWound Ltd. | -15.29 Million USD | -116920.118% |
| OmniAb, Inc. | -69.41 Million USD | -25674.465% |
| Alector, Inc. | -151.74 Million USD | -11691.47% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -16469.623% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -34210.762% |
| Zai Lab Limited | -366.57 Million USD | -4780.986% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -5548.256% |
| Aura Biosciences, Inc. | -84.99 Million USD | -20952.083% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -7188.167% |
| Immunic, Inc. | -99.22 Million USD | -17932.488% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -12398.342% |
| Veracyte, Inc. | -85.79 Million USD | -20754.8% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -6248.979% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -125813.976% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -259663.555% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -95109.603% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 3192.464% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -70195.745% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 46211.994% |
| TG Therapeutics, Inc. | 20.63 Million USD | 86817.278% |
| Galecto, Inc. | -39.9 Million USD | -44737.429% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -42425.969% |
| Fortrea Holdings Inc. | 63.1 Million USD | 28455.588% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -12639.774% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -61858.501% |
| XBiotech Inc. | -37.51 Million USD | -47600.283% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -25883.323% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -26557.294% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -16481.447% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -69596.074% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -33474.225% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -3043.381% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -22695.159% |
| Vaxxinity, Inc. | -58.28 Million USD | -30598.08% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -17152.481% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -80303.851% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -20604.934% |
| NexImmune, Inc. | -29.19 Million USD | -61191.045% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -318262.202% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -122607.031% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 542.104% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -70179.178% |
| Scopus BioPharma Inc. | -11.71 Million USD | -152632.086% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -13981.611% |
| Ainos, Inc. | -13.2 Million USD | -135382.656% |
| Pluri Inc. | -22.15 Million USD | -80649.057% |
| Prothena Corporation plc | -191.03 Million USD | -9265.971% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -12861.921% |
| Celularity Inc. | -192.28 Million USD | -9205.037% |
| Rallybio Corporation | -78.93 Million USD | -22568.089% |
| Cue Biopharma, Inc. | -52.14 Million USD | -34210.104% |
| MeiraGTx Holdings plc | -137.06 Million USD | -12954.316% |
| Omeros Corporation | -164.53 Million USD | -10774.841% |
| Humacyte, Inc. | -100.04 Million USD | -17783.971% |
| Immunocore Holdings plc | -59.64 Million USD | -29896.104% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -96308.082% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -72980.815% |
| Blueprint Medicines Corporation | -486.27 Million USD | -3579.462% |
| CalciMedica, Inc. | -21.87 Million USD | -81693.719% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -23865.143% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -13507.922% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -10345.358% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -5373.348% |
| Pulmatrix, Inc. | -14.74 Million USD | -121286.54% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -49955.605% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -20034.108% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -3372.286% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -26387.211% |
| Cytokinetics, Incorporated | -496.2 Million USD | -3505.844% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -51884.009% |
| Nutriband Inc. | -4.87 Million USD | -367154.675% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -40925.327% |
| Vor Biopharma Inc. | -126.03 Million USD | -14096.242% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 521.789% |
| Evogene Ltd. | -26.39 Million USD | -67697.264% |
| ProKidney Corp. | -151.52 Million USD | -11708.434% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -27625.073% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -232502.874% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -2845.877% |
| CorMedix Inc. | -48.95 Million USD | -36446.537% |
| BioLineRx Ltd. | -49.69 Million USD | -35905.103% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -15571.285% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -46896.155% |
| Atai Life Sciences N.V. | -125.47 Million USD | -14160.168% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -21816.377% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -21878.376% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -7086.039% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -58105.517% |
| MediciNova, Inc. | -9.9 Million USD | -180626.233% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -14058.385% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -246948.357% |
| GeoVax Labs, Inc. | -26.74 Million USD | -66805.047% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -7618.053% |
| Biomea Fusion, Inc. | -126.13 Million USD | -14085.1% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -5020.857% |
| Mereo BioPharma Group plc | -28.41 Million USD | -62865.85% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -9263.373% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -7680.85% |
| Absci Corporation | -115.51 Million USD | -15389.223% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -64757.998% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -15752.619% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -7288.598% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -70912.764% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -8502.352% |
| Allakos Inc. | -196.05 Million USD | -9026.156% |
| Imunon, Inc. | -21.03 Million USD | -84978.508% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -16068.199% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 16777.892% |
| BioAtla, Inc. | -129.68 Million USD | -13696.584% |
| NLS Pharmaceutics AG | -11.8 Million USD | -151439.6% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -112835.53% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -5359.37% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -42747.78% |
| XOMA Corporation | -41.84 Million USD | -42655.63% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -16901.982% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -14626.841% |
| aTyr Pharma, Inc. | -54.91 Million USD | -32479.574% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -20365.504% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -10250.191% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -6931.785% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -83252.166% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -217760.827% |
| Akari Therapeutics, Plc | -16.8 Million USD | -106364.215% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -202332991.712% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 5400.283% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -273734.034% |
| UroGen Pharma Ltd. | -65.53 Million USD | -27201.599% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -19941.193% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -246249.256% |
| Orgenesis Inc. | -53.63 Million USD | -33258.893% |
| Entera Bio Ltd. | -8.89 Million USD | -201141.435% |
| GH Research PLC | -41.22 Million USD | -43304.92% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -69498.475% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -21443.323% |
| Xencor, Inc. | -138.63 Million USD | -12805.731% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -347015.877% |
| Replimune Group, Inc. | -234.77 Million USD | -7521.139% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -83154.74% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -128142.374% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -273734.034% |
| Portage Biotech Inc. | -18.25 Million USD | -97924.303% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -246948.357% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -16946.69% |
| OncoCyte Corporation | -25.13 Million USD | -71082.272% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -158171.582% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -156068.986% |
| Purple Biotech Ltd. | 22.27 Million USD | 80439.347% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -238083.919% |
| scPharmaceuticals Inc. | -55.39 Million USD | -32199.04% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -94580.213% |
| HilleVax, Inc. | -133.34 Million USD | -13318.108% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -148396.772% |
| Tharimmune, Inc. | -9.45 Million USD | -189132.784% |
| Genprex, Inc. | -31.07 Million USD | -57476.984% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -9407.41% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -56923.858% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -2338772.68% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -328386.177% |
| OKYO Pharma Limited | -15.74 Thousand USD | -113604234.804% |
| Savara Inc. | -60 Million USD | -29717.148% |
| Curis, Inc. | -48.33 Million USD | -36919.73% |
| Daré Bioscience, Inc. | -30.83 Million USD | -57917.009% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -342844.523% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -245775.718% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -65560.095% |
| BeiGene, Ltd. | -1.2 Billion USD | -1381.481% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -89634.223% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -3572.604% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -19005.172% |
| Erasca, Inc. | -141.52 Million USD | -12542.555% |
| bluebird bio, Inc. | -244.26 Million USD | -7225.076% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -395139.204% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 9301.956% |
| DBV Technologies S.A. | -76.43 Million USD | -23309.535% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -395139.204% |
| Moderna, Inc. | -4.23 Billion USD | -322.09% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -41892.011% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -281226.667% |
| Molecular Templates, Inc. | -10.46 Million USD | -170857.157% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -26510.908% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -4649.213% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -12384.998% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -34313.048% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -11477.679% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -8496.731% |
| MacroGenics, Inc. | -168.24 Million USD | -10534.778% |
| RenovoRx, Inc. | -11.39 Million USD | -156905.756% |
| Adicet Bio, Inc. | -152.03 Million USD | -11668.358% |
| Prime Medicine, Inc. | -191.29 Million USD | -9253.437% |
| Aditxt, Inc. | -26.06 Million USD | -68552.0% |
| Adagene Inc. | -23.71 Million USD | -75332.028% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -244662.464% |
| Quantum-Si incorporated | -111.17 Million USD | -15994.463% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -56435.566% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -122637.418% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 14764.199% |
| SciSparc Ltd. | -5.77 Million USD | -309832.028% |
| Vericel Corporation | -6.46 Million USD | -276700.371% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -206589.043% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -77290.589% |
| Generation Bio Co. | -138.56 Million USD | -12812.809% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -21449.291% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -20594.397% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -7321.112% |
| Invivyd, Inc. | -207.78 Million USD | -8511.088% |
| Relay Therapeutics, Inc. | -373 Million USD | -4696.884% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -190680.704% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 83393.962% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -173831.914% |
| 2seventy bio, Inc. | -216.7 Million USD | -8156.635% |
| ADMA Biologics, Inc. | 21.63 Million USD | 82812.537% |
| Clene Inc. | -40.54 Million USD | -44035.116% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -74210.494% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -32552.705% |
| GeoVax Labs, Inc. | -26.74 Million USD | -66805.047% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -5011.231% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -48610.572% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 111391.758% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -17153.646% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -52521.54% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -10407.744% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -2514.679% |
| Evaxion Biotech A/S | -22.19 Million USD | -80507.181% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -21618.793% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -7919.028% |
| Trevena, Inc. | -35.28 Million USD | -50603.854% |
| Surrozen, Inc. | -45.78 Million USD | -38983.39% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -22280.857% |
| Cingulate Inc. | -22.75 Million USD | -78516.049% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 238919.754% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -39957.259% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -217200.27% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -17346.105% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -24283.51% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -28724.268% |
| Clearmind Medicine Inc. | -8.74 Million USD | -204586.641% |
| Kronos Bio, Inc. | -121.83 Million USD | -14586.347% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -23382.041% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -609939.806% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -17645.62% |
| Statera Biopharma, Inc. | -98.34 Million USD | -18093.7% |
| ImmunityBio, Inc. | -362.25 Million USD | -4839.234% |
| Korro Bio, Inc. | -84.53 Million USD | -21065.893% |
| Kineta, Inc. | -15.72 Million USD | -113697.469% |
| BioVie Inc. | -32.17 Million USD | -55501.637% |
| Codexis, Inc. | -68.06 Million USD | -26185.645% |
| Celularity Inc. | -192.28 Million USD | -9205.037% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -7937.616% |
| Celcuity Inc. | -66.23 Million USD | -26915.381% |
| Virax Biolabs Group Limited | -6.49 Million USD | -275316.768% |
| Cibus, Inc. | -318.88 Million USD | -5510.953% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -41510.177% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -52767.202% |
| IN8bio, Inc. | -30.33 Million USD | -58878.726% |
| Kodiak Sciences Inc. | -277.32 Million USD | -6351.865% |
| Annexon, Inc. | -143.72 Million USD | -12349.209% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -14353.697% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -27577.468% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -76219.638% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -4958.201% |
| Eyenovia, Inc. | -25.4 Million USD | -70324.553% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 54917.328% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -321589.608% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -22510.511% |
| Arcellx, Inc. | -89.88 Million USD | -19806.96% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -39300.106% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -12940.425% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -57415.111% |
| Moolec Science SA | -6.65 Million USD | -268804.424% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -29165.557% |
| Geron Corporation | -193.94 Million USD | -9125.537% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -41266.786% |
| Royalty Pharma plc | 1.49 Billion USD | 1299.1% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -10799.219% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -191716.392% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -81620.266% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -10366.01% |
| Humacyte, Inc. | -100.04 Million USD | -17783.971% |
| Structure Therapeutics Inc. | -102.77 Million USD | -17309.269% |
| 89bio, Inc. | -151.2 Million USD | -11733.269% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -22228.628% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -122956.231% |
| Genelux Corporation | -24.16 Million USD | -73942.524% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -52644.085% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -10317.686% |
| Notable Labs, Ltd. | -14.65 Million USD | -121973.931% |
| Liquidia Corporation | -73.38 Million USD | -24281.849% |
| Mustang Bio, Inc. | -50.72 Million USD | -35172.594% |
| Immunovant, Inc. | -282.7 Million USD | -6228.902% |
| Quantum-Si incorporated | -111.17 Million USD | -15994.463% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -22808.692% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -84032.111% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -17439.482% |
| Acasti Pharma Inc. | -11.31 Million USD | -158071.641% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -77960.704% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -111871.787% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -8258.814% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -487553.99% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -112529.838% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -61265.627% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -43135.009% |
| PepGen Inc. | -84.76 Million USD | -21007.963% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -60283.976% |
| United Therapeutics Corporation | 1.18 Billion USD | 1610.033% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -78042.883% |
| Solid Biosciences Inc. | -104.31 Million USD | -17052.256% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -54436.431% |
| Immuneering Corporation | -58.41 Million USD | -30530.871% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -351403.86% |
| Silo Pharma, Inc. | -3.85 Million USD | -463963.003% |
| Belite Bio, Inc | -31.66 Million USD | -56399.861% |
| XOMA Corporation | -41.84 Million USD | -42655.63% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -26399.372% |
| Apogee Therapeutics, Inc. | -93 Million USD | -19138.493% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 50246.794% |
| uniQure N.V. | -282.87 Million USD | -6225.278% |
| Cassava Sciences, Inc. | -105.95 Million USD | -16786.45% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -244662.464% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -13716.08% |
| Forte Biosciences, Inc. | -32.48 Million USD | -54977.192% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -215243.647% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -60768.774% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -321589.608% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -125813.976% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -201186.714% |
| Altimmune, Inc. | -95.92 Million USD | -18551.686% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -24245.356% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 50246.794% |
| Compugen Ltd. | -12.99 Million USD | -137618.411% |
| Peak Bio, Inc. | -1356.23 USD | -1319272884.671% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -35970.43% |
| Benitec Biopharma Inc. | -22.49 Million USD | -79457.03% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -7284.298% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -60050.528% |
| Zura Bio Limited | -62.63 Million USD | -28464.731% |
| PolyPid Ltd. | -22.86 Million USD | -78145.402% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -109831.04% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -60050.528% |
| Instil Bio, Inc. | -159.16 Million USD | -11141.119% |
| argenx SE | -425.04 Million USD | -4109.485% |
| Immunome, Inc. | -109.53 Million USD | -16235.594% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -35426.827% |
| Verona Pharma plc | -67.83 Million USD | -26277.913% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -68558.388% |
| Shattuck Labs, Inc. | -91.95 Million USD | -19357.329% |
| CervoMed Inc. | -7.81 Million USD | -228910.834% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -24373.227% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -134217.063% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -37041.147% |
| Moolec Science SA | -6.65 Million USD | -268804.424% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -108678.559% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -13131.397% |
| AnaptysBio, Inc. | -164.41 Million USD | -10782.712% |
| Design Therapeutics, Inc. | -78.19 Million USD | -22783.202% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -20456.262% |
| NeurAxis, Inc. | -6.66 Million USD | -268373.095% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -44079.797% |
| Lumos Pharma, Inc. | -36.61 Million USD | -48767.581% |
| Achilles Therapeutics plc | -75.25 Million USD | -23675.664% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -68558.388% |
| 180 Life Sciences Corp. | -13.47 Million USD | -132657.381% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 347099.551% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -609939.806% |
| Nutriband Inc. | -4.87 Million USD | -367154.675% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -16051.269% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -32168.167% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -35096.27% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -26969.057% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -32958.671% |
| Palisade Bio, Inc. | -13.07 Million USD | -136796.526% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -39302.709% |
| Beam Therapeutics Inc. | -176.48 Million USD | -10038.185% |
| Neurogene Inc. | -55.58 Million USD | -32090.375% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -16291.865% |
| AEON Biopharma, Inc. | -48.42 Million USD | -36845.582% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -18401.061% |
| Sesen Bio, Inc. | -25.9 Million USD | -68958.536% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -21320.556% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -142050.821% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -3784.926% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -24599.921% |
| Athira Pharma, Inc. | -125.46 Million USD | -14160.737% |
| Vaccinex, Inc. | -22.88 Million USD | -78083.858% |
| HCW Biologics Inc. | -25.71 Million USD | -69473.685% |
| XOMA Corporation | -41.84 Million USD | -42655.63% |
| Nektar Therapeutics | -137.42 Million USD | -12919.739% |
| Arvinas, Inc. | -401.5 Million USD | -4356.383% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -202332991.712% |
| Merus N.V. | -156.54 Million USD | -11329.396% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -17745.798% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -51582.195% |
| Rezolute, Inc. | -70.42 Million USD | -25307.006% |
| Clene Inc. | -40.54 Million USD | -44035.116% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -109143.242% |
| BeyondSpring Inc. | -23.11 Million USD | -77309.258% |
| Synlogic, Inc. | -55.16 Million USD | -32336.642% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -99695.728% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -165202.809% |
| Peak Bio, Inc. | -1356.23 USD | -1319272884.671% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -44075.434% |
| Krystal Biotech, Inc. | -109.72 Million USD | -16206.266% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -13712.24% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -5116.238% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -376902.806% |
| MannKind Corporation | 8.67 Million USD | 206280.871% |
| Ikena Oncology, Inc. | -75.41 Million USD | -23624.593% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -185370.882% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -26513.678% |
| Gossamer Bio, Inc. | -183.75 Million USD | -9636.871% |
| CohBar, Inc. | -12.38 Million USD | -144329.666% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -35173.985% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -64757.998% |
| Legend Biotech Corporation | -439.48 Million USD | -3971.214% |
| Mural Oncology plc | -194.63 Million USD | -9092.643% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -26548.163% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -110721.163% |
| Disc Medicine, Inc. | -91.12 Million USD | -19534.981% |
| Champions Oncology, Inc. | -7.35 Million USD | -243135.128% |
| REGENXBIO Inc. | -268.12 Million USD | -6573.073% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -166834.725% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -31990.494% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -45824.232% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -15546.07% |
| Vaxart, Inc. | -83.34 Million USD | -21367.331% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -209904.216% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -41710.397% |
| Cellectis S.A. | -106.62 Million USD | -16680.5% |
| Longeveron Inc. | -21.02 Million USD | -84984.293% |
| Repare Therapeutics Inc. | -116.22 Million USD | -15294.734% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -6580.647% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -23553.085% |
| Revolution Medicines, Inc. | -487.18 Million USD | -3572.604% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -268877.39% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -40607.048% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -23887.634% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -25594.516% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -162395.468% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 515.377% |
| Denali Therapeutics Inc. | -196.69 Million USD | -8996.323% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -206589.043% |
| Veru Inc. | -93.78 Million USD | -18978.645% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -76595.855% |
| Cingulate Inc. | -22.75 Million USD | -78516.049% |
| Passage Bio, Inc. | -108.38 Million USD | -16407.557% |
| Context Therapeutics Inc. | -25.07 Million USD | -71262.222% |
| Exicure, Inc. | -14.99 Million USD | -119214.324% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -8582.922% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -43972.063% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -184035.968% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -9605.287% |
| Nuvalent, Inc. | -149.49 Million USD | -11868.785% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -217661.29% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -20064.741% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -86028.699% |
| OmniAb, Inc. | -69.41 Million USD | -25674.465% |
| Anew Medical, Inc. | -1.3 Million USD | -1375347.864% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -140001.605% |
| Lipocine Inc. | -17.93 Million USD | -99684.836% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -26015.301% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -23395.609% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -46892.057% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -45166.213% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -79833.774% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -2985.696% |
| Ocugen, Inc. | -65.53 Million USD | -27203.682% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -18961.615% |
| Q32 Bio Inc. | -92.1 Million USD | -19326.696% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -83357.139% |
| Alumis Inc. Common Stock | -158.17 Million USD | -11211.831% |
| Equillium, Inc. | -14.52 Million USD | -123108.759% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -28570.923% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -226289.8% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -94743.751% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -38008.615% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -16395.838% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -149376.638% |
| Dominari Holdings Inc. | -21.79 Million USD | -81990.182% |
| Edesa Biotech, Inc. | -9.22 Million USD | -193902.445% |
| vTv Therapeutics Inc. | -25.5 Million USD | -70060.678% |
| Bio-Techne Corporation | 206.68 Million USD | 8756.791% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -4470.363% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 9417.49% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -13426.445% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -46505.652% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -11741.335% |
| Nkarta, Inc. | -131.65 Million USD | -13490.867% |
| BioCardia, Inc. | -11.64 Million USD | -153561.766% |
| Iterum Therapeutics plc | -47.46 Million USD | -37593.554% |